302 related articles for article (PubMed ID: 26356670)
1. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
[TBL] [Abstract][Full Text] [Related]
2. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
[TBL] [Abstract][Full Text] [Related]
3. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
Shin I; Kim S; Song H; Kim HR; Moon A
J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
6. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
7. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells.
Deng D; Yang S; Wang X
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412051
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
Gao J; Yan Q; Wang J; Liu S; Yang X
J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
[TBL] [Abstract][Full Text] [Related]
10. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
[TBL] [Abstract][Full Text] [Related]
11. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
12. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
[TBL] [Abstract][Full Text] [Related]
13. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
15. Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathway.
Kim JH; Kim JH; Kim SC; Yi YS; Yang WS; Yang Y; Kim HG; Lee JY; Kim KH; Yoo BC; Hong S; Cho JY
Biochem Pharmacol; 2013 Nov; 86(9):1285-300. PubMed ID: 23994169
[TBL] [Abstract][Full Text] [Related]
16. Mesothelin promotes invasion and metastasis in breast cancer cells.
Wang Y; Wang L; Li D; Wang HB; Chen QF
J Int Med Res; 2012; 40(6):2109-16. PubMed ID: 23321167
[TBL] [Abstract][Full Text] [Related]
17. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
Sankpal NV; Fleming TP; Gillanders WE
Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
19. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.
Guo J; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247
[No Abstract] [Full Text] [Related]
20. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells.
Liu P; Wilson MJ
J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
